169 related articles for article (PubMed ID: 24459400)
1. Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis.
Soni MP; Shelkar N; Gaikwad RV; Vanage GR; Samad A; Devarajan PV
J Pharm Bioallied Sci; 2014 Jan; 6(1):22-30. PubMed ID: 24459400
[TBL] [Abstract][Full Text] [Related]
2. Shape mediated splenotropic delivery of buparvaquone loaded solid lipid nanoparticles.
Maithania HV; Mohanty BS; Chaudhari PR; Samad A; Devarajan PV
Drug Deliv Transl Res; 2020 Feb; 10(1):159-167. PubMed ID: 31468307
[TBL] [Abstract][Full Text] [Related]
3. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization.
Varia JK; Dodiya SS; Sawant KK
Curr Drug Deliv; 2008 Jan; 5(1):64-9. PubMed ID: 18220553
[TBL] [Abstract][Full Text] [Related]
5. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
[TBL] [Abstract][Full Text] [Related]
6. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
Vivek K; Reddy H; Murthy RS
AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
[TBL] [Abstract][Full Text] [Related]
7. Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles.
Lingling G; Yuan Z; Weigen L
Drug Dev Ind Pharm; 2016 Aug; 42(8):1325-33. PubMed ID: 26821124
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery.
Bhalekar MR; Pokharkar V; Madgulkar A; Patil N; Patil N
AAPS PharmSciTech; 2009; 10(1):289-96. PubMed ID: 19294517
[TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
10. Halobetasol propionate-loaded solid lipid nanoparticles (SLN) for skin targeting by topical delivery.
Bikkad ML; Nathani AH; Mandlik SK; Shrotriya SN; Ranpise NS
J Liposome Res; 2014 Jun; 24(2):113-23. PubMed ID: 24131382
[TBL] [Abstract][Full Text] [Related]
11. Preparation of Curcumin Solid Lipid Nanoparticles Loaded with Flower-Shaped Lactose for Lung Inhalation and Preliminary Evaluation of Cytotoxicity In Vitro.
Li N; Li X; Cheng P; Yang P; Shi P; Kong L; Liu H
Evid Based Complement Alternat Med; 2021; 2021():4828169. PubMed ID: 34745284
[TBL] [Abstract][Full Text] [Related]
12. Design Optimization and Evaluation of Solid Lipid Nanoparticles of Azelnidipine for the treatment of Hypertension.
Kanugo A; Dugad T
Recent Pat Nanotechnol; 2022 Oct; ():. PubMed ID: 36278461
[TBL] [Abstract][Full Text] [Related]
13. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats.
Rawat MK; Jain A; Singh S
J Pharm Sci; 2011 Jun; 100(6):2406-17. PubMed ID: 21491451
[TBL] [Abstract][Full Text] [Related]
14. Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery.
Pathak P; Nagarsenker M
AAPS PharmSciTech; 2009; 10(3):985-92. PubMed ID: 19641997
[TBL] [Abstract][Full Text] [Related]
15. Development of andrographolide-loaded solid lipid nanoparticles for lymphatic targeting: Formulation, optimization, characterization, in vitro, and in vivo evaluation.
Shrivastava S; Kaur CD
Drug Deliv Transl Res; 2023 Feb; 13(2):658-674. PubMed ID: 35978260
[TBL] [Abstract][Full Text] [Related]
16. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
Garg A; Singh S
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
[TBL] [Abstract][Full Text] [Related]
17. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
18. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.
Thatipamula R; Palem C; Gannu R; Mudragada S; Yamsani M
Daru; 2011; 19(1):23-32. PubMed ID: 22615636
[TBL] [Abstract][Full Text] [Related]
19. Characterization of ergocalciferol loaded solid lipid nanoparticles.
Patel MR; San Martin-Gonzalez MF
J Food Sci; 2012 Jan; 77(1):N8-13. PubMed ID: 22260120
[TBL] [Abstract][Full Text] [Related]
20. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
Attama AA; Müller-Goymann CC
Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]